Research & Development



  雲瑯心中暗暗嘆息一聲,就知道是這個答案。   抱著李敢馬腿的老嫗掙扎著站起來,大聲道︰“我是!”2014福利彩票春节放假   伊秩斜掀開牛車的簾子,看著劉陵道︰“漢人真的來了!”2014福利彩票休市   雲瑯跟司馬遷在橋頭堡上一連下了三盤棋,霍去病,李敢依舊沒有來,而白登山上的戰斗卻似乎在不斷地減弱。   老家伙們的話不能听,而且,誰听誰倒霉,這是一群已經失去奮斗動力的老家伙,他們對所有人都會笑臉相迎的,因為他們已經對這個世界沒了更多的要求,只求保住自己已經獲得富貴生活。3.6亿彩票作假   “老夫最討厭的就是聰明人,一個個仗著自己有一點小聰明就敢胡亂揣測上官的心思,經常拿一些狗屁不通的道理來給自己當逃命的借口。到了戰場,你們就認命吧,老夫不管你有什麼理由,敢在同袍血戰的時候逃跑,老夫一定會要你人頭落地,哪怕不殺匈奴了,也要先殺你!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo